| The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial H Yanai, A Levine, A Hirsch, RS Boneh, U Kopylov, HB Eran, NA Cohen, ... The Lancet Gastroenterology & Hepatology 7 (1), 49-59, 2022 | 119 | 2022 |
| Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls J Shapiro, NA Cohen, V Shalev, A Uzan, O Koren, N Maharshak The Journal of dermatology 46 (7), 595-603, 2019 | 116 | 2019 |
| Novel indications for fecal microbial transplantation: update and review of the literature NA Cohen, N Maharshak Digestive diseases and sciences 62, 1131-1145, 2017 | 85 | 2017 |
| Use of faecal transplantation with a novel diet for mild to moderate active ulcerative colitis: the craft UC randomised controlled trial C Sarbagili Shabat, F Scaldaferri, E Zittan, A Hirsch, MC Mentella, ... Journal of Crohn's and Colitis 16 (3), 369-378, 2022 | 68 | 2022 |
| The effect of a multispecies probiotic on microbiota composition in a clinical trial of patients with diarrhea‐predominant irritable bowel syndrome K Hod, R Dekel, N Aviv Cohen, A Sperber, Y Ron, M Boaz, S Berliner, ... Neurogastroenterology & Motility 30 (12), e13456, 2018 | 56 | 2018 |
| Fecal transplantation for treatment of Clostridium difficile infection in elderly and debilitated patients T Friedman-Korn, DM Livovsky, N Maharshak, N Aviv Cohen, K Paz, ... Digestive diseases and sciences 63, 198-203, 2018 | 48 | 2018 |
| New targets in inflammatory bowel disease therapy: 2021 NA Cohen, DT Rubin Current opinion in gastroenterology 37 (4), 357-363, 2021 | 45 | 2021 |
| Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study NA Cohen, N Plevris, U Kopylov, A Grinman, B Ungar, H Yanai, ... United European Gastroenterology Journal 8 (9), 1076-1085, 2020 | 41 | 2020 |
| Alterations of enteric microbiota in patients with a normal ileal pouch are predictive of pouchitis N Maharshak, NA Cohen, L Reshef, H Tulchinsky, U Gophna, I Dotan Journal of Crohn's and Colitis 11 (3), 314-320, 2017 | 36 | 2017 |
| A retrospective comparison of fecal microbial transplantation methods for recurrent Clostridium difficile infection NA Cohen, DM Livovsky, S Yaakobovitch, M Ben Yehoyada, R Ben Ami, ... Isr Med Assoc J 18 (10), 594-9, 2016 | 36 | 2016 |
| Clostridium difficile fecal toxin level is associated with disease severity and prognosis NA Cohen, T Miller, W Na’aminh, K Hod, A Adler, D Cohen, H Guzner-Gur, ... United European gastroenterology journal 6 (5), 773-780, 2018 | 30 | 2018 |
| Upadacitinib is effective and safe in both ulcerative colitis and Crohn’s disease: prospective real-world experience S Friedberg, D Choi, T Hunold, NK Choi, NM Garcia, EA Picker, ... Clinical Gastroenterology and Hepatology 21 (7), 1913-1923. e2, 2023 | 25 | 2023 |
| Inclusion of under-represented racial and ethnic minorities in randomized clinical trials for inflammatory bowel disease NA Cohen, A Silfen, DT Rubin Gastroenterology 162 (1), 17-21, 2022 | 21 | 2022 |
| Five years of fecal microbiota transplantation-an update of the Israeli experience SA Greenberg, I Youngster, NA Cohen, DM Livovsky, J Strahilevitz, ... World journal of gastroenterology 24 (47), 5403, 2018 | 19 | 2018 |
| Treat‐to‐target and sequencing therapies in Crohn's disease NM Garcia, NA Cohen, DT Rubin United European gastroenterology journal 10 (10), 1121-1128, 2022 | 18 | 2022 |
| Fecal microbiota transplantation for Clostridium difficile-associated diarrhea NA Cohen, R Ben Ami, H Guzner-Gur, ME Santo, Z Halpern, ... Isr Med Assoc J 17 (8), 510-514, 2015 | 16 | 2015 |
| Sphingosine-1 phosphate receptor Modulators: the next wave of oral therapies in inflammatory bowel disease T Choden, NA Cohen, DT Rubin Gastroenterology & Hepatology 18 (5), 265, 2022 | 13 | 2022 |
| Short-term effectiveness and safety of tofacitinib in ulcerative colitis-real world data from tertiary medical centers in Israel I Avni-Biron, ABG Shitrit, B Koslowsky, A Levartovsky, U Kopylov, ... Digestive and Liver Disease 54 (2), 192-197, 2022 | 13 | 2022 |
| Risk factors for malnutrition among IBD patients L Einav, A Hirsch, Y Ron, NA Cohen, S Lahav, J Kornblum, R Anbar, ... Nutrients 13 (11), 4098, 2021 | 13 | 2021 |
| Delays in therapy associated with current prior authorization process for the treatment of inflammatory bowel disease DK Choi, NA Cohen, T Choden, RD Cohen, DT Rubin Inflammatory Bowel Diseases 29 (10), 1658-1661, 2023 | 12 | 2023 |
